Clinical Trials
8 trialsNCT00093704 2020-07-31
Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma
Jonsson Comprehensive Cancer Center
Phase 1 Terminated
NCT00002824 2019-03-13
Gene Therapy in Treating Patients With Primary Brain Tumors
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT00530218 2017-12-02
Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant
City of Hope Medical Center
Phase 2 Completed
NCT00716911 2015-06-08
Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant
City of Hope Medical Center
Phase NA Completed
NCT02202564 2014-07-29
Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma
Huazhong University of Science and Technology
Phase 2 Completed
NCT00006340 2013-07-26
Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus
Boston Medical Center
Phase 1 Completed
NCT00964756 2013-02-13
A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers
University of Alabama at Birmingham
Phase 1 Completed
NCT00006480 2010-09-21
Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma
Fred Hutchinson Cancer Center
Phase 1 Completed